Infantile NeutropeniaSymptoms, Doctors, Treatments, Advances & More
Infantile Neutropenia Overview
Learn About Infantile Neutropenia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Elio Castagnola practices practicing medicine in Genoa, Italy. Mr. Castagnola is rated as an Elite expert by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Infantile Neutropenia, Febrile Neutropenia, Agranulocytosis, Bone Marrow Transplant, and Splenectomy.
Monica Slavin practices practicing medicine in Melbourne, Australia. Ms. Slavin is rated as an Elite expert by MediFind in the treatment of Infantile Neutropenia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Infantile Neutropenia, Bone Marrow Transplant, and Lung Transplant.
Franco Locatelli practices practicing medicine in Rome, Italy. Mr. Locatelli is rated as an Elite expert by MediFind in the treatment of Infantile Neutropenia. He is also highly rated in 69 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Splenectomy.
Background: * Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocytes (a type of white blood cell), which can lead to opportunistic infections or autoimmune disorders and diseases.
Summary: This multisite prospective study seeks to determine if HLA-identical sibling donor transplantation using alemtuzumab, low dose total-body irradiation, and sirolimus (Sickle transplant Using a Nonmyeloablative approach, SUN) can decrease the toxicity of transplant while achieving a high cure rate for children with sickle cell disease (SCD).


